News
Ressler, J. M., et al. (2025) Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial).Nature Cancer.doi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback